Industry News
FDA approves Gilead's antiviral remdesivir drug for treatment of COVID-19
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients